Remove news quest-diagnostics-acquire-pathai-diagnostics-accelerate-ai-and-digital-pathology-adoption
article thumbnail

Quest Diagnostics To Acquire PathAI Diagnostics To Accelerate AI and Digital Pathology Adoption in Cancer Diagnosis; Forms Licensing Agreements With PathAI

3BL Media

Under the terms of a definitive agreement, Quest will acquire select assets of PathAI Diagnostics, the business of PathAI that provides anatomic and digital pathology laboratory services. In addition, Quest will be a preferred provider for PathAI's biopharmaceutical clinical laboratory services.